Literature DB >> 18249187

Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.

Yun-Hye Jin1, Yeon-Jin Kim, Dae-Won Kim, Kwang-Hyun Baek, Bok Yun Kang, Chang-Yeol Yeo, Kwang-Youl Lee.   

Abstract

Sirt2 is a mammalian member of the Sirtuin family of NAD(+) (nicotinamide adenine dinucleotide)-dependent protein deacetylases. Although Sir-2.1 (a Caenorhabditis elegans Sirt2 ortholog) has been reported to interact with PAR-5/FTT-2 (a C. elegans 14-3-3 homolog), the molecular significance of the interaction between Sirt2 and 14-3-3 proteins in mammalian cell is not understood. Here, we report that Sirt2 interacts with 14-3-3 beta and gamma among various 14-3-3 isoforms, and that this interaction is strengthened by AKT. Furthermore, Sirt2 deacetylates and down-regulates the transcriptional activity of p53, and 14-3-3 beta/gamma augment deacetylation and down-regulation of the p53 transcriptional activity by Sirt2 in an AKT-dependent manner. Treatment of cells with nicotinamide, an inhibitor of Sirtuins, relieves the inhibition of p53 by Sirt2 and 14-3-3 beta/gamma. Therefore, our results suggest that the interaction between Sirt2 and 14-3-3 beta/gamma is a novel mechanism for the negative regulation of p53 beside the well-characterized Mdm2-mediated repression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18249187     DOI: 10.1016/j.bbrc.2008.01.114

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  14-3-3 proteins play a role in the cell cycle by shielding cdt2 from ubiquitin-mediated degradation.

Authors:  Ashraf Dar; David Wu; Nicholas Lee; Etsuko Shibata; Anindya Dutta
Journal:  Mol Cell Biol       Date:  2014-08-25       Impact factor: 4.272

2.  SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.

Authors:  Hyun-Seok Kim; Athanassios Vassilopoulos; Rui-Hong Wang; Tyler Lahusen; Zhen Xiao; Xiaoling Xu; Cuiling Li; Timothy D Veenstra; Bing Li; Hongtao Yu; Junfang Ji; Xin Wei Wang; Seong-Hoon Park; Yong I Cha; David Gius; Chu-Xia Deng
Journal:  Cancer Cell       Date:  2011-10-18       Impact factor: 31.743

Review 3.  Calorie restriction and the exercise of chromatin.

Authors:  Alejandro Vaquero; Danny Reinberg
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

4.  Molecular cloning, expression and subcellular distribution of an alternative splice variant of the porcine Sirt2 gene.

Authors:  Bingting Liu; Fei Liu; Liang Bai; Yucheng Li; Gongshe Yang
Journal:  Mol Biol Rep       Date:  2009-10-13       Impact factor: 2.316

5.  Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.

Authors:  Mohammad A Khanfar; Luisa Quinti; Hua Wang; Soo Hyuk Choi; Aleksey G Kazantsev; Richard B Silverman
Journal:  Eur J Med Chem       Date:  2014-02-06       Impact factor: 6.514

6.  Specific ablation of Nampt in adult neural stem cells recapitulates their functional defects during aging.

Authors:  Liana R Stein; Shin-ichiro Imai
Journal:  EMBO J       Date:  2014-05-08       Impact factor: 11.598

7.  The interaction between acetylation and serine-574 phosphorylation regulates the apoptotic function of FOXO3.

Authors:  Z Li; B Bridges; J Olson; S A Weinman
Journal:  Oncogene       Date:  2016-09-26       Impact factor: 9.867

Review 8.  The sirtuin family's role in aging and age-associated pathologies.

Authors:  Jessica A Hall; John E Dominy; Yoonjin Lee; Pere Puigserver
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

9.  Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibition.

Authors:  Lisa M Giammona; Swapna Panuganti; Jan M Kemper; Pani A Apostolidis; Stephan Lindsey; Eleftherios T Papoutsakis; William M Miller
Journal:  Exp Hematol       Date:  2009-08-26       Impact factor: 3.084

Review 10.  Myelin proteomics: molecular anatomy of an insulating sheath.

Authors:  Olaf Jahn; Stefan Tenzer; Hauke B Werner
Journal:  Mol Neurobiol       Date:  2009-05-19       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.